Event summary

Cooley Rx is a virtual series focused on the life sciences and healthcare sectors. Join us as we discuss the top issues and trends in these industries – and provide decision-makers with information they can use to strengthen their organizations.

Life Sciences Litigation: Biosimilars, 2025 Year in Review

2025 featured numerous significant developments in the biosimilars landscape – in the courtroom, at the Food and Drug Administration and at the Patent and Trademark Office – that could greatly affect the strategy of originators and biosimilars alike in Biologics Price Competition and Innovation Act (BPCIA) litigation over the upcoming years. 

Cooley lawyers Brianna Patterson and Geoff Biegler will recap the most important biosimilar cases, decisions, industry developments and government initiatives from the past year. The discussion will include an overview of 2025’s biosimilar approvals, biosimilar-related litigations and post-grant proceedings, and developments in the regulation of biosimilars, as well as what to watch for in 2026. 

This program is designed for in-house lawyers and executives interested in the latest topics and trends in biosimilars litigation, whether they are new to the field or have decades of experience. 

For more information, please email Megan Senerchia.

Continuing legal education (CLE) credits

Attendees may earn up to 1.0 CLE credit for participating in this live webinar. Credit will not be granted for on-demand viewing.

Cooley LLP is an approved provider and may provide credit in CA, CO, IL, NY, PA and TX.

Cooley LLP is a sponsor and will apply for credit in FL, OH, VA and WA.

Credit in other jurisdictions may be available via reciprocity.

If you have specific CLE credit questions, please contact Cooley’s licensing and compliance team.

Details and registration

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.